Fairmount Funds Management as of June 30, 2023
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 17 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axsome Therapeutics (AXSM) | 23.8 | $169M | 2.3M | 71.86 | |
| Nuvalent Inc-a (NUVL) | 17.1 | $122M | 2.9M | 42.17 | |
| ImmunoGen | 16.0 | $114M | 6.0M | 18.87 | |
| Enliven Therapeutics (ELVN) | 6.1 | $43M | 2.1M | 20.41 | |
| Cogent Biosciences (COGT) | 5.9 | $42M | 3.6M | 11.84 | |
| Merus N V (MRUS) | 5.5 | $39M | 1.5M | 26.33 | |
| Miragen Therapeutics (VRDN) | 4.6 | $33M | 1.4M | 23.79 | |
| Argenx Se Sponsored Adr (ARGX) | 4.0 | $29M | 74k | 389.73 | |
| Tyra Biosciences (TYRA) | 3.4 | $24M | 1.4M | 17.03 | |
| Terns Pharmaceuticals (TERN) | 2.5 | $18M | 2.0M | 8.75 | |
| Astria Therapeutics (ATXS) | 2.2 | $16M | 1.9M | 8.33 | |
| Kodiak Sciences (KOD) | 1.9 | $14M | 2.0M | 6.90 | |
| Dbv Technologies Sa Sponsored Adr | 1.9 | $13M | 7.1M | 1.90 | |
| Trevi Therapeutics (TRVI) | 1.7 | $12M | 5.2M | 2.39 | |
| Kiniksa Pharmaceuticals Com Cl A | 1.4 | $9.9M | 705k | 14.08 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.1 | $8.1M | 382k | 21.14 | |
| Aeglea Biotherapeutics | 0.6 | $4.3M | 9.5M | 0.45 |
